Support for people recovering from opioid overdoses in Seattle

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates a new sub-acute stabilization center (SASC) designed for individuals who have experienced or are at risk of opioid overdoses. Participants will be referred by Seattle Fire Department emergency medical services and will receive comprehensive care, including monitoring, medication-assisted treatment, and linkage to ongoing support services. The study will compare outcomes for those who utilize the SASC with those who do not, using data from EMS records and stakeholder interviews to assess implementation and effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Verbally consents to transfer of care to SASC.
2. Awake and oriented to person and place, with no significant deficits in mental status or neurological function.
3. Age \>=18
4. Patent airway and effective respirations with adequate oxygenation.
5. Stable heart rate and blood pressure, with no evidence of cardiac arrhythmias or other significant cardiovascular disfunction.
6. Vitals:

   * Heart rate: 45-130
   * Blood pressure: systolic 95-190, diastolic 50-120
   * Respiratory rate: 10-24
   * SpO2: \>92 on room air or supplemental O2 via nasal cannula.
   * SpO2 \<92% with supplemental O2 requires ED transfer.
   * EtCO2: \<50
   * Temperature: 95.5-100.3 F
   * Blood glucose (if indicated): 60-300
7. No signs of head trauma:

   * Dizziness or loss of balance
   * Blurred vision or double vision
   * Sensitivity to light or noise
   * Seizures or convulsions
   * Weakness or numbness in the arms or legs
   * Persistent or worsening headache
   * CSF or blood leaking from the nose or ears
   * Unequal pupils or pupils that are slow to react to light.
8. No signs of other traumatic injury or medical needs requiring immediate treatment.
9. No signs of respiratory infection. Screen for COVID-19. See COVID-19 Screening protocol.

Exclusion Criteria:

\- People under 18 and who do not meet SASC admission criteria will be excluded.

Where it's running

• Downtown Emergency Service Center's Overdose Recovery and Care Access Centers
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Caleb Banta-Green, PhD, MPH, MSW — University of Washington
• Study coordinator: Anthony S Floyd, PhD
• Email: asfloyd@uw.edu
• Phone: 206-616-7382

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brief alcohol-focused program tailored for people taking buprenorphine

  This project will try a short, opioid-informed alcohol counseling program for adults on prescribed buprenorphine who drink alcohol to see if it reduces drinking and helps them stay in treatment.

  Recruiting University of Notre Dame · Notre Dame, Indiana · NCT07342504

• Lemborexant for insomnia in adults with opioid use disorder on buprenorphine

  This trial will see if taking lemborexant each night for 8 weeks improves sleep, mood, and impulsive behavior in adults with moderate opioid use disorder who are stable on buprenorphine.

  Recruiting Phase 2 Virginia Commonwealth University · Richmond, Virginia · NCT06981195

• Translating and validating a questionnaire for opioid misuse in Swedish pain patients

  This study is testing a new Swedish questionnaire to see if it can help identify opioid misuse among pain patients who are using opioids for treatment.

  Recruiting Uppsala University · Uppsala, Uppland · NCT06084520

• Non-invasive treatment for opioid withdrawal using vagal nerve stimulation

  This study is testing whether a non-invasive treatment using Vagal Nerve Stimulation can help people with opioid use disorders feel better during withdrawal and reduce cravings.

  Recruiting at 5 sites Phase 3 Emory University · Atlanta, Georgia and 5 other locations · NCT05834478

• Community-based program for youth with opioid use disorder

  This study is testing a community program that helps young people with opioid use disorder get better treatment and support to see if it keeps them engaged in recovery and reduces overdoses.

  Recruiting Phase 4 The University of Texas Health Science Center, Houston · Houston, Texas · NCT04811014

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.